Clinical data implies that the presence of CD36 + cells correlates with a poor prognosis and greater invasion numerous types of carcinomas, and inhibition of CD36 also impairs metastasis, in human melanoma and breast cancer-derived tumors (Ben-Shoshan et al., 2008; Liang et al., 2018, 3). This evidence concerns the gene CD36 and breast cancer.